Russell B. Lingham

2.3k citations

50 papers · 1.7k indexed · h-index 27

Co-authors: Sheo B. Singh Keith C. Silverman Deborah L. Zink George M. Stancel David S. Loose‐Mitchell Gerald F. Bills Michael Goetz Peter J. Felock
Topics: Microbial Natural Products and Biosynthesis (14 papers)Protein Kinase Regulation and GTPase Signaling (9 papers)HIV/AIDS drug development and treatment (6 papers)
Cited by: Pharmacology Biotechnology Virology
Journals: Journal of the American Chemical Society PLoS ONE Biochemistry
Partner nations: United States Spain Canada

In The Last Decade

Russell B. Lingham

50 papers receiving 1.6k citations

Peers

Countries citing papers authored by Russell B. Lingham

Since Specialization

Citations

This map shows the geographic impact of Russell B. Lingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell B. Lingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell B. Lingham more than expected).

Fields of papers citing papers by Russell B. Lingham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell B. Lingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell B. Lingham. The network helps show where Russell B. Lingham may publish in the future.

Co-authorship network of co-authors of Russell B. Lingham

This figure shows the co-authorship network connecting the top 25 collaborators of Russell B. Lingham. A scholar is included among the top collaborators of Russell B. Lingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell B. Lingham. Russell B. Lingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics 2020 ·Trends in biotechnology ·Renata E. Gordon,Jennifer F. Nemeth,Sanjaya Singh,Russell B. Lingham,Iqbal S. Grewal	18
2	Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody 2018 ·Molecular Metabolism ·Simon A. Hinke,(unknown),Thomas Kirchner,Katharine D’Aquino,Rupesh Nanjunda,Jason Aligo,Robert A. Perkinson,Philip Cooper,(unknown),Mark L. Chiu,(unknown),Eilyn R. Lacy,Yin Liang,Dana L. Johnson,Jean M. Whaley,Russell B. Lingham,Anthony J. Kihm	12
3	TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway 2015 ·PLoS ONE ·Brian Tomkowicz,Eileen S. Walsh,(unknown),Raluca Verona,(unknown),Fred M. Kaplan,(unknown),(unknown),Jill M. Mooney,Russell B. Lingham,Michael Naso,Timothy J. McCabe	57
4	Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Thomas S. Reger,(unknown),Nicholas Stock,Bowei Wang,Nicholas D. Smith,Benito Muñoz,Mitchell D. Green,Michael F. Gardner,Joyce James,Weichao Chen,(unknown),Qian Si,(unknown),Russell B. Lingham,Richard A. Mumford	7
5	Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist 2009 ·Bioorganic & Medicinal Chemistry Letters ·Shankar Venkatraman,Alec D. Lebsack,(unknown),Michael F. Gardner,Joyce James,Russell B. Lingham,Salony Maniar,Richard A. Mumford,Qian Si,Nicholas Stock,(unknown),Bowei Wang,(unknown),Benito Muñoz	6
6	Influence of acid surrogates toward potency of VLA-4 antagonist 2005 ·Bioorganic & Medicinal Chemistry Letters ·Shankar Venkatraman,Jongwon Lim,Merryl Cramer,Michael F. Gardner,Joyce James,(unknown),Russell B. Lingham,Richard A. Mumford,Benito Muñoz	6
7	Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease 2004 ·Biochemical and Biophysical Research Communications ·Sheo B. Singh,John G. Ondeyka,(unknown),Carolyn L. Ruby,Vinod Sardana,Marvin Schulman,(unknown),Fernando Peláez,Mark W. Stahlhut,Sanjeev Munshi,David B. Olsen,Russell B. Lingham	33
8	Four novel bis-(naphtho-γ-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sheo B. Singh,Deborah L. Zink,Gerald F. Bills,Ana Teran,Keith C. Silverman,Russell B. Lingham,Peter J. Felock,Daria J. Hazuda	37
9	Efficient syntheses, human and yeast farnesyl-protein transferase inhibitory activities of chaetomellic acids and analogues 2000 ·Bioorganic & Medicinal Chemistry ·Sheo B. Singh,Hiranthi Jayasuriya,Keith C. Silverman,(unknown),Joanne M. Williamson,Russell B. Lingham	29
10	Resorcylic Acid Lactones. Naturally Occurring Potent and Sclective Inbibitors. 1999 ·The Journal of Antibiotics ·Annie Zhao,(unknown),(unknown),Rosalind G. Jenkins,Denis R. Patrick,Hans E. Huber,Michael Goetz,Otto D. Hensens,Deborah L. Zink,Dolores Vilella,Anne W. Dombrowski,Russell B. Lingham,Leeyuan Huang	100
11	Kampanols: novel ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis 1998 ·Bioorganic & Medicinal Chemistry Letters ·Sheo B. Singh,Deborah L. Zink,(unknown),Jon D. Polishook,Manuel Sánchez,Keith C. Silverman,Russell B. Lingham	34
12	Oreganic Acid, a Potent Inhibitor of Ras Farnesyl-Protein Transferase 1997 ·Biochemical and Biophysical Research Communications ·Keith C. Silverman,Hiranthi Jayasuriya,Carmen Cascales,Dolores Vilella,Gerald F. Bills,Rosalind G. Jenkins,Sheo B. Singh,Russell B. Lingham	13
13	Oreganic acid: a potent novel inhibitor of ras farnesyl-protein transferase from an endophytic fungus 1996 ·Bioorganic & Medicinal Chemistry Letters ·Hiranthi Jayasuriya,Gerald F. Bills,Carmen Cascales,Deborah L. Zink,Michael Goetz,Rosalind G. Jenkins,Keith C. Silverman,Russell B. Lingham,Sheo B. Singh	17
14	Quinoxapeptins: Novel Chromodepsipeptide Inhibitors of HIV-1 and HIV-2 Reverse Transcriptase. I. The Producing Organism and Biological Activity. 1996 ·The Journal of Antibiotics ·Russell B. Lingham,Amy Hsu,(unknown),J Sigmund,(unknown),(unknown),Brian K. Heimbuch,Olga Genilloud,I. Martín,Maria Teresa Dı́ez,C. F. Hirsch,Deborah L. Zink,Jerrold M. Liesch,Gregory Koch,Suzanne Gartner,George M Garrity,Nancy N. Tsou,Gino Salituro	45
15	Barceloneic Acid A, a New Farnesyl-Protein Transferase Inhibitor from a Phoma Species 1995 ·Journal of Natural Products ·Hiranthi Jayasuriya,Richard G. Ball,Deborah L. Zink,Jack L. Smith,Michael Goetz,Rosalind G. Jenkins,Mary Nallin-Omstead,Keith C. Silverman,Gerald F. Bills,Russell B. Lingham,Sheo B. Singh,Fernando Peláez,Carmen Cascales	40
16	Actinoplanic Acid A: A Macrocyclic Polycarboxylic Acid Which Is a Potent Inhibitor of Ras Farnesyl-Protein Transferase 1994 ·Journal of the American Chemical Society ·Sheo B. Singh,Jerrold M. Liesch,Russell B. Lingham,Michael Goetz,W. Wayt Gibbs	18
17	Microbial Transformation of L-696, 474, a Novel Cytochalasin as an Inhibitor of HIV-1 Protease 1993 ·Journal of Natural Products ·(unknown),George A. Doss,(unknown),Amy Hsu,Russell B. Lingham,Raymond F. White,Richard L. Monaghan	13
18	L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. I. The producing organism and its fermentation. 1992 ·The Journal of Antibiotics ·Anne W. Dombrowski,Gerald F. Bills,(unknown),Lawrence R. Koupal,Richard F. Meyer,John G. Ondeyka,R.A. Giacobbe,Richard L. Monaghan,Russell B. Lingham	42
19	HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502 1991 ·Biochemical and Biophysical Research Communications ·Russell B. Lingham,Byron H. Arison,(unknown),Amy Hsu,(unknown),Wayne J. Thompson,George M Garrity,(unknown),Frederick W. Hartner,Paul L. Darke,Suresh K. Balani,Steven M. Pitzenberger,(unknown),Harri G. Ramjit,Edward Inamine,L. Treiber	5
20	Estrogen Regulation of Epidermal Growth Factor Receptor Messenger Ribonucleic Acid 1988 ·Molecular Endocrinology ·Russell B. Lingham,George M. Stancel,David S. Loose‐Mitchell	141

About Russell B. Lingham

Russell B. Lingham is a scholar working on Pharmacology, Biotechnology and Virology, having authored 50 papers that have together received 1.7k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (14 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Pharmacology (576 citations), Biotechnology (201 citations) and Virology (99 citations). Russell B. Lingham has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Sheo B. Singh, Keith C. Silverman, Deborah L. Zink, George M. Stancel, David S. Loose‐Mitchell, Gerald F. Bills, Michael Goetz, Peter J. Felock, Daria J. Hazuda and Rosalind G. Jenkins. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact